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Pregnancy and
Emerging Diseases 
To the Editor: The November
2006 issue of Emerging Infectious
Diseases featured 2 perspectives (1,2)
that highlighted the need for strate-
gies to prevent and treat pregnant
patients during outbreaks of new or
emerging diseases or during bioter-
rorist attacks. However, neither arti-
cle discussed implications for a sur-
veillance strategy.
Based on my previous experience
at the World Health Organization
(WHO) with the severe acute respira-
tory syndrome (SARS) outbreak, I
propose several practical steps for
such a strategy: l) systematic identifi-
cation and reporting of cases in preg-
nant women, 2) estimation of the
number of cases in pregnant women,
3) international clinical networks to
share treatment and infection control
experience, and 4) standard protocols
for sharing clinical and treatment
information between nations.
First, cases in pregnant patients
should be systematically identified
and reported during outbreaks, by
including information on pregnancy
status and duration of the pregnancy
in case-report forms for new diseases.
This is important for several reasons.
First, case-patients that come to atten-
tion in an ad hoc fashion may provide
a biased view of outcome, since those
with a poor outcome are more likely
to draw attention. Second, although
pregnancy is not rare, the number of
cases in pregnant women in outbreaks
of new or emerging diseases in any 1
location may be too small for mean-
ingful analysis.
Unfortunately, during the SARS
epidemic, pregnancy status was not
included on the international case-
reporting forms. Although some coun-
tries systematically tested for and
recorded pregnancy status, other
countries did not. As a result, valuable
information was lost, and outcomes
for pregnant women could not be
properly assessed.
A rough estimate can be made of
the number of pregnant women in a
particular country likely to have a par-
ticular disease such as SARS.
Assuming equal attack rates for preg-
nant and nonpregnant women, the
number of pregnant women having a
disease can be estimated as equal to
three fourths of the sum over 5-year
age groups of the product of the num-
ber of female patients in the 5-year
age group by the age-specific fertility
rate for that age group.1,2,3 While the
assumption of equal attack rates does
not hold for all infectious diseases, it
is a good starting point for a new dis-
ease about which there is little infor-
mation.
Using this method for SARS
resulted in an estimate of 119 cases in
pregnant women (Table). For most
countries, the estimated number of
pregnant case-patients was reasonably
close to the total number of pregnant
case-patients that could be identified
in the scientific literature through web
searches (column 3) supplemented by
cases identified through informal
sources, such as emails and at WHO
meetings and conference calls (col-
umn 4). China was an exception; 84
pregnant case-patients were estimated
for China, but only 5 case-patients
were identified, all from the same
hospital in China.
These estimates have limitations.
They do not consider subnational dif-
ferences in fertility, such as differ-
ences for specific ethnic or occupa-
tional groups, or rural-urban differ-
ences. Nonetheless, they provide a
ballpark figure that can be used to
assess the extent of pregnancy-related
cases. 
The estimates were useful during
the SARS outbreak in raising aware-
ness of the issues surrounding preg-
nancy and SARS. As a result of such
awareness, WHO formed a clinical
network to share clinical experiences
regarding treatment of pregnant
patients as well as experiences with
infection control during obstetrical
procedures. Although this network
was established rather late during the
SARS outbreak, it did result in useful
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1It is necessary to multiply by 3/4, because live births take 9 months, on average.
2The estimated number of pregnant women is based on expected number of live births,
and the estimate does not take into consideration fetal loss, premature delivery, or multi-
ple births.
3Estimates can be made by using an electronic spreadsheet. Age-specific fertility rates
can be drawn from United Nations Population Division data available for all countries.LETTERS
interchanges between nationals in dif-
ferent countries during conference
calls.
The network discussed the estab-
lishment of a standardized database
for sharing detailed clinical informa-
tion on the course, outcome, and treat-
ment of pregnant SARS patients.
However, this database was never cre-
ated. Although, fortunately, the scien-
tific literature contains summaries of
experiences with 20 case-patients, this
is not a substitute for a systematic and
reasonably complete database of
experiences. To be sure that such a
database is established for any new
disease, protocols for data sharing
should be prepared in advance, and all
possible administrative barriers to
sharing information should be
addressed.
In conclusion, pregnant women
are an important group at high risk for
outbreaks of new diseases. This situa-
tion requires appropriate strategies for
surveillance. I have identified several
measures that I believe could be used
in this regard.
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In response:We thank Ms. Anker
for describing some of the surveillance
challenges during the severe acute res-
piratory syndrome (SARS) pandemic
and for supporting the idea that during
an infectious disease outbreak or pub-
lic health emergency, pregnant women
are a population deserving special
consideration (1). We also understand
and appreciate the challenges she
describes in systematically identifying
and reporting pregnancies during a
public health emergency response
such as occurred with SARS. In the
aftermath of Hurricane Katrina, we
have recognized that it is critical that
pregnancy information be collected
systematically as part of the medical
intake process. This can be accom-
plished by asking a simple, short ques-
tion about pregnancy status (i.e.,“Are
you or do you think you could be preg-
nant?”) as women are being evaluated
and processed as part of an emergency
response plan. Urine pregnancy test-
ing may be used to verify pregnancy
status for women who are unsure (2).
Besides helping tailor the provision of
healthcare in these settings, pregnancy
status information should also be used
to track pregnancy outcomes.
We agree with Ms. Anker regard-
ing the importance of pregnancy sur-
veillance efforts. In June 2003 the
Centers for Disease Control and
Prevention (CDC) announced the first
evidence of community-acquired
monkeypox in the United States.
Because this outbreak was linked to
infected prairie dogs often kept as pets
by small children, exposed household
members included mothers, some of
whom were pregnant. Unfortunately,
although outbreaks of monkeypox in
Africa had previously been well
described, these descriptions did not
include much information on the nat-
ural history of monkeypox among
pregnant women (3). This example
highlights the importance of ensuring
that pregnancy information is system-
atically collected to plan and respond
to future outbreaks.
In addition to surveillance of
pregnant women in a known outbreak
or emergency response, pregnant
women should be included in efforts
to detect novel disease threats.
Unusual patterns of disease among
pregnant women may be an early sign
of emerging disease in the general
population. In their role as frontline
physicians, obstetrician-gynecologists
and other healthcare providers who
care for pregnant women may be
among the first to encounter patients
with novel infectious disease threats
(4).
Finally, with Ms. Anker, we sup-
port coordinated international efforts
to collect and monitor the pregnancy
status of affected women during an
outbreak or emergency response and
are working on ways at CDC to pre-
pare for future threats.
Denise J. Jamieson,* 
Sonja A. Rasmussen,* 
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